BioLine RX Ltd BLRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:08 PM EDT
0.6825quote price arrow up+0.0131 (+1.957%)
Volume
224,766
52 week range
0.55 - 2.53
Loading...
  • Open0.66
  • Day High0.6996
  • Day Low0.6511
  • Prev Close0.6694
  • 52 Week High2.53
  • 52 Week High Date09/05/23
  • 52 Week Low0.55
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap54.559M
  • Shares Out79.94M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change-56.52

KEY STATS

  • Open0.66
  • Day High0.6996
  • Day Low0.6511
  • Prev Close0.6694
  • 52 Week High2.53
  • 52 Week High Date09/05/23
  • 52 Week Low0.55
  • 52 Week Low Date04/26/24
  • Market Cap54.559M
  • Shares Out79.94M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change-56.52

RATIOS/PROFITABILITY

  • EPS (TTM)-0.95
  • P/E (TTM)-0.72
  • Fwd P/E (NTM)-0.66
  • EBITDA (TTM)-41.607M
  • ROE (TTM)-189.23%
  • Revenue (TTM)4.80M
  • Gross Margin (TTM)23.08%
  • Net Margin (TTM)-1,262.79%
  • Debt To Equity (MRQ)87.66%

EVENTS

  • Earnings Date05/04/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioLine RX Ltd

 

Profile

MORE
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Aharon Schwartz Ph.D.
Chairman of the Board
Philip Serlin
Chief Executive Officer
Mali Zeevi
Chief Financial Officer
Ella Sorani
Vice President - Development
Abi Vainstein-Haras
Vice President-Clinical & Medical Affairs
Address
Modi'in Technology Park
2 HaMa'ayan Street
Modiin
7177871
Israel

Top Peers

SYMBOLLASTCHG%CHG
GENE
Genetic Technologies Ltd
2.25-0.06-2.80%
HCWB
HCW Biologics Inc
1.35-0.05-3.57%
ICCC
ImmuCell Corp
5.07+0.16+3.31%
DYAI
Dyadic International Inc
1.47+0.04+2.79%
KRON
Kronos Bio Inc
0.9863-0.0437-4.2427%